Leveraging the Medicines for Malaria Venture malaria and pathogen boxes to discover chemical inhibitors of East Coast fever
Chemotherapy of East Coast fever, a lymphoproliferative cancer-like disease of cattle causing significant economic losses in Africa, is largely dependent on the use of buparvaquone, a drug that was developed in the late 1980's. The disease is caused by the tick-borne protozoan pathogen Theileri...
Main Authors: | James Nyagwange, Elias Awino, Edwin Tijhaar, Nicholas Svitek, Roger Pelle, Vishvanath Nene |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221132071830174X |
Similar Items
-
Novel Antifungal Compounds Discovered in Medicines for Malaria Venture’s Malaria Box
by: Eric H. Jung, et al.
Published: (2018-03-01) -
Screening the Medicines for Malaria Venture Pathogen Box against piroplasm parasites
by: Arifin Budiman Nugraha, et al.
Published: (2019-08-01) -
Screening the Medicines for Malaria Venture "Malaria Box" against the Plasmodium falciparum aminopeptidases, M1, M17 and M18.
by: Alessandro Paiardini, et al.
Published: (2015-01-01) -
Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture
by: Tadele M, et al.
Published: (2020-03-01) -
Targeted Phenotypic Screening in Plasmodium falciparum and Toxoplasma gondii Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules
by: Gowtham Subramanian, et al.
Published: (2018-01-01)